Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2012, Article ID 802796, 6 pages
http://dx.doi.org/10.1155/2012/802796
Research Article

A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment

1Department of Neurology, Turku University Hospital and University of Turku, Kiinamyllynkatu 4-8, 20520 Turku, Finland
24Pharma Ltd., 20520 Turku, Finland

Received 15 June 2012; Accepted 28 June 2012

Academic Editor: Sreeram Ramagopalan

Copyright © 2012 J. Åivo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Beatriz Pozuelo-Moyano, Julian Benito-Leon, Alex J. Mitchell, and Jesus Hernandez-Gallego, “A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis,” Neuroepidemiology, vol. 40, no. 3, pp. 147–153, 2013. View at Publisher · View at Google Scholar
  • Jan Dörr, Andrea Döring, and Friedemann Paul, “Can we prevent or treat multiple sclerosis by individualised vitamin D supply?,” The EPMA journal, vol. 4, no. 1, pp. 4, 2013. View at Publisher · View at Google Scholar
  • Cierra N. Treu, Niels Bergsland, Murali Ramanathan, Bianca Weinstock-Guttman, Caitlin Turner, Kerri O'Connor, Michael G. Dwyer, Deepa P. Ramasamy, Robert Zivadinov, Jun Qu, and Ellen Carl, “Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis,” Journal Of Neurology Neurosurgery And Psychiatry, vol. 84, no. 10, pp. 1075–1081, 2013. View at Publisher · View at Google Scholar
  • Anthony T. Reder, and Xuan Feng, “How Type I Interferons Work in Multiple Sclerosis and Other Diseases: Some Unexpected Mechanisms,” Journal of Interferon and Cytokine Research, vol. 34, no. 8, pp. 589–599, 2014. View at Publisher · View at Google Scholar
  • Eman M Faruk, Mohamed M Yousef, and Taha Mohamed, “Does vitamin D have protective effect on human nasal polyposis: histological and immunohistochemical study,” Journal of Histology and Histopathology, vol. 1, no. 1, pp. 2, 2014. View at Publisher · View at Google Scholar
  • Gorm Pihl-Jensen, and Jette Lautrup Frederiksen, “25-Hydroxyvitamin D levels in acute monosymptomatic optic neuritis: relation to clinical severity, paraclinical findings and risk of multiple sclerosi,” Journal Of Neurology, vol. 262, no. 7, pp. 1646–1654, 2015. View at Publisher · View at Google Scholar
  • Claire McCarthy, and John Thorpe, “Some recent advances in multiple sclerosis.,” Journal of neurology, vol. 263, no. 9, pp. 1880–6, 2016. View at Publisher · View at Google Scholar
  • Sofia F.G. Zorzella-Pezavento, Larissa L.W. Ishikawa, Thais F.C. Fraga-Silva, Luiza A.N. Mimura, and Alexandrina Sartori, “Therapeutic and Prophylactic Potential of Vitamin D for Multiple Sclerosis,” A Critical Evaluation of Vitamin D - Clinical Overview, 2017. View at Publisher · View at Google Scholar
  • Vanitha A Jagannath, Graziella Filippini, Carlo Di Pietrantonj, G V Asokan, Edward W Robak, Liz Whamond, and Sarah A Robinson, “Vitamin D for the management of multiple sclerosis,” Cochrane Database of Systematic Reviews, 2018. View at Publisher · View at Google Scholar
  • Andika Okparasta, Muhammad Iman Indrasyah, Hasnawi Haddani, and Erial Bahar, “Effect of vitamin D3 supplementation towards vitamin D serum levels and Myasthenia Gravis Composite Score (MGCS),” Journal of Physics: Conference Series, vol. 1246, pp. 012032, 2019. View at Publisher · View at Google Scholar